(NASDAQ:CGIX) From a buy rating to a strong-buy rating in a report " "
Cancer Genetics (NASDAQ:CGIX) Stock Rating Upgraded by ValuEngine " " Posted by Faye Duncan on Nov 27th, 2019 // "
dakotafinancialnews.com/201...
" A hedge fund recently raised its stake in Cancer Genetics stock. Renaissance Technologies LLC boosted its stake in shares of Cancer Genetics Inc (NASDAQ:CGIX) by 38.4% "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.